Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
107.59 USD
0.49%
Market Closed
Updated:
Apr 24, 2024
Abbott Laboratories
Accumulated Depreciation
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Accumulated Depreciation Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Accumulated Depreciation
$-11.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accumulated Depreciation
$-7.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accumulated Depreciation
$-3.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Accumulated Depreciation
$-3.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accumulated Depreciation
$-1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbott Laboratories's Accumulated Depreciation?
Accumulated Depreciation
-11.8B
USD
-11.8B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Accumulated Depreciation amounts to -11.8B USD.
What is Abbott Laboratories's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 10Y
-5%
-5%
Over the last year, the Accumulated Depreciation growth was -4%. The average annual Accumulated Depreciation growth rates for Abbott Laboratories have been -6% over the past three years , -7% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
